Tim Estilow

Validation of the Charcot–Marie–Tooth disease pediatric scale as an outcome measure of disability

Joshua Burns, Robert Ouvrier, Tim Estilow et al. · Annals of Neurology · 2012 · 178 citations

Medicine, Neurology, Pediatrics +17

Biallelic mutations in SORD cause a common and potentially treatable hereditary neuropathy with implications for diabetes

Andrea Cortese, Yi Zhu, Adriana Rebelo et al. · Nature Genetics · 2020 · 177 citations · Full text

Medicine, Genetics, Molecular Genetics +11

Assessing non-Mendelian inheritance in inherited axonopathies

Dana M. Bis‐Brewer, Ziv Gan‐Or, Patrick Sleiman et al. · Genetics in Medicine · 2020 · 27 citations · Full text

Life Sciences, Genetics, Neuroscience +11

Refining clinical trial inclusion criteria to optimize the standardized response mean of the CMTPedS

Kayla Cornett, Manoj P. Menezes, Paula Bray et al. · Annals of Clinical and Translational Neurology · 2020 · 27 citations · Full text

Medicine, Child Health, Pediatrics +15

Transitioning outcome measures: relationship between the CMTPedS and CMTNSv2 in children, adolescents, and young adults with Charcot‐Marie‐Tooth disease

Joshua Burns, Manoj P. Menezes, Richard S. Finkel et al. · Journal of the Peripheral Nervous System · 2013 · 21 citations · Full text

Medicine, Neurology, Pediatrics +13